secwatch.observer — SEC 8-K summary
======================================

Issuer:     STAAR SURGICAL CO (STAA)
CIK:        0000718937
Form:       8-K/A
Filed at:   2024-10-31T23:59:59+00:00
Accession:  0000950170-24-119230
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STAAR Surgical reports Q3 net sales up 10% to $88.6M; revises 2024 regional growth assumptions
--------------------------------------------------------------------------------

- Net income of $10.0M ($0.20 EPS) vs $4.8M ($0.10 EPS) a year ago; adjusted EBITDA $16.2M.
- ICL sales $89.1M, up 10%; gross margin 77.3% vs 79.2% on lower production absorption.
- FY 2024 net sales outlook maintained at $340-345M; adjusted EBITDA ~$42M.
- Americas EVO ICL growth revised to 17% (was 15%); U.S. to 20% (was 25%); EMEA to 10% (was 6%).
- APAC growth cut to 5% (was 7%); China growth slashed to ~2% (was 10%); other APAC now 10-20% (was flat).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/718937/000095017024119230/0000950170-24-119230-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/718937/000095017024119230/staa-20241030.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-119230

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer